Buckle Up: DOJ Initiates Rulemaking to Reschedule Marijuana
FDA Law Blog
MAY 21, 2024
The 2016 reviews concluded that marijuana continued to meet schedule I criteria for having a high potential for abuse, no currently accepted medical use in treatment in the U.S., and lacked accepted safety for use under medical supervision. Currently Accepted Medical Use in Treatment in the U.S. 21 U.S.C. § 21 U.S.C. §
69 
Let's personalize your content